there's no money to be made from running a definitive diet or exercise trial.
a product such as bisantrene can ultimately be sold for big bucks if shown to help just a little bit.
who can make serious money out of recommending that women undergoing breast cancer treatment engage in an active exercise program? Small studies have shown exercise helps with response, but who would be prepared to fund major trials equivalent to a phase 3 trial to definitively prove and quantify the benefits of exercise as an adjunct cancer intervention?
this is a real bugbear for me: a lot of cancers probably have a big life-style contribution, yet there is no easy money to fund proper life-style treatment interventions.
if I wanted to float a biotech company on the ASX to test the benefits of a ketogenic diet and exercise as an adjunct to conventional cancer treatment, would anyone invest in my IPO?
course not! That would be stupid!
Pillar 1 - FTO (new thread), page-47
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.055(4.37%) |
Mkt cap ! $218.5M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.33 | $1.26 | $149.9K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.29 |
Change
0.055 ( 4.34 %) |
||||
| Open | High | Low | Volume | ||
| $1.26 | $1.33 | $1.26 | 12903 | ||
| Last updated 15.43pm 09/05/2024 ? | |||||
| RAC (ASX) Chart |